Amphastar Pharmaceuticals AMPH Change in AR
Change in AR at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's change in ar.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's change in AR?
- Amphastar Pharmaceuticals (AMPH) reported change in AR of $4.55M in Q1 2026.
- How has Amphastar Pharmaceuticals's change in AR changed year-over-year?
- Amphastar Pharmaceuticals's change in AR decreased by 43.7% year-over-year, from $8.08M to $4.55M.
- What does change in AR mean?
- Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.